Alberta Investment Management Corp (AIMCo)’s Ionis Pharmaceuticals IONS Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-101,426	Closed	-$3.62M	–	1261
2023 Q1	$3.62M	Hold	101,426	–	–	0.04%	403
2022 Q4	$3.83M	Buy	+101,426	New	+$4.27M	0.03%	483
2019 Q1	–	Sell	-44,100	Closed	-$2.38M	–	929
2018 Q4	$2.38M	Buy	+44,100	New	+$2.25M	0.03%	396
2018 Q3	–	Sell	-11,900	Closed	-$496K	–	841
2018 Q2	$496K	Buy	+11,900	New	+$528K	﹤0.01%	705

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s IONS Position: Q2 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Ionis Pharmaceuticals (IONS) in Q2 2023, closing a stake of 101,426 shares — an estimated $3.62M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in IONS in Q2 2018 and held it in 4 quarters. The position peaked at $3.83M in Q4 2022. 304 funds tracked by Wall St. Rank hold IONS as of Q2 2023.

Alberta Investment Management Corp (AIMCo) reported no remaining Ionis Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 101,426 Ionis Pharmaceuticals shares in Q2 2023, an estimated $3.62M.
Alberta Investment Management Corp (AIMCo) first reported a position in Ionis Pharmaceuticals in Q2 2018 and held it in 4 quarters.
Alberta Investment Management Corp (AIMCo)'s Ionis Pharmaceuticals position peaked at $3.83M in Q4 2022.
304 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2023, filed 14 Aug 2023.